Orion S.A. (OEC) stock
OECNYSEMiscellaneous Chemical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3085% below fair value
$3.97−0.02 (-0.50%)
Close on Nov 12, 2026Market cap $224.40MP/E –Yield 2.02%
Orion EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Orion's EPS for the twelve months ending Sep 30, 2026 was -$0.58. For fiscal 2025 it was -$1.24, down 263.2% from the year before. The highest annual figure on record is $2.21 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.24 | -263.2% |
| FY2024 | Dec 31, 2024 | $0.76 | -56.1% |
| FY2023 | Dec 31, 2023 | $1.73 | 0.0% |
| FY2022 | Dec 31, 2022 | $1.73 | -21.7% |
| FY2021 | Dec 31, 2021 | $2.21 | +636.7% |
| FY2020 | Dec 31, 2020 | $0.30 | -78.9% |
| FY2019 | Dec 31, 2019 | $1.42 | -28.6% |
| FY2018 | Dec 31, 2018 | $1.99 | +86.0% |
| FY2017 | Dec 31, 2017 | $1.07 | +30.5% |
| FY2016 | Dec 31, 2016 | $0.82 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.05 | – |
| Q2 FY2026 | Jun 30, 2026 | $0.03 | -81.3% |
| Q1 FY2026 | Mar 31, 2026 | -$0.18 | -212.5% |
| Q4 FY2025 | Dec 31, 2025 | -$0.38 | -226.7% |
| Q3 FY2025 | Sep 30, 2025 | -$1.20 | – |
| Q2 FY2025 | Jun 30, 2025 | $0.16 | -54.3% |
| Q1 FY2025 | Mar 31, 2025 | $0.16 | -64.4% |
| Q4 FY2024 | Dec 31, 2024 | $0.30 | +275.0% |
| Q3 FY2024 | Sep 30, 2024 | -$0.35 | -179.5% |
| Q2 FY2024 | Jun 30, 2024 | $0.35 | -31.4% |
| Q1 FY2024 | Mar 31, 2024 | $0.45 | -35.7% |
| Q4 FY2023 | Dec 31, 2023 | $0.08 | -60.0% |
| Q3 FY2023 | Sep 30, 2023 | $0.44 | -15.4% |
| Q2 FY2023 | Jun 30, 2023 | $0.51 | +4.1% |
| Q1 FY2023 | Mar 31, 2023 | $0.70 | +32.1% |
| Q4 FY2022 | Dec 31, 2022 | $0.20 | +900.0% |
| Q3 FY2022 | Sep 30, 2022 | $0.52 | +48.6% |
| Q2 FY2022 | Jun 30, 2022 | $0.49 | -66.7% |
| Q1 FY2022 | Mar 31, 2022 | $0.53 | +35.9% |
| Q4 FY2021 | Dec 31, 2021 | $0.02 | -86.7% |
| Q3 FY2021 | Sep 30, 2021 | $0.35 | +133.3% |
| Q2 FY2021 | Jun 30, 2021 | $1.47 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.39 | +34.5% |
| Q4 FY2020 | Dec 31, 2020 | $0.15 | -51.6% |
| Q3 FY2020 | Sep 30, 2020 | $0.15 | -61.5% |
| Q2 FY2020 | Jun 30, 2020 | -$0.29 | -172.5% |
| Q1 FY2020 | Mar 31, 2020 | $0.29 | -9.4% |
| Q4 FY2019 | Dec 31, 2019 | $0.31 | +24.0% |
| Q3 FY2019 | Sep 30, 2019 | $0.39 | -9.3% |
| Q2 FY2019 | Jun 30, 2019 | $0.40 | -54.0% |
| Q1 FY2019 | Mar 31, 2019 | $0.32 | -27.3% |
| Q4 FY2018 | Dec 31, 2018 | $0.25 | +4.2% |
| Q3 FY2018 | Sep 30, 2018 | $0.43 | +72.0% |
| Q2 FY2018 | Jun 30, 2018 | $0.87 | +190.0% |
| Q1 FY2018 | Mar 31, 2018 | $0.44 | – |
| Q4 FY2017 | Dec 31, 2017 | $0.24 | – |
| Q3 FY2017 | Sep 30, 2017 | $0.25 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.30 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?